Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jolana Markovà, Ute Essner, Bülent Akmaz, Marcella Marinelli, Christiane Trompke, Arnd Lentschat & Carlos Vila. (2019) Sativex® as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial. International Journal of Neuroscience 129:2, pages 119-128.
Read now
Read now
Rafael Arroyo González. (2018) A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis. Expert Review of Neurotherapeutics 18:10, pages 785-791.
Read now
Read now
Articles from other publishers (22)
Alessio Baricich, Marco Battaglia, Daria Cuneo, Lucia Cosenza, Marzia Millevolte, Michela Cosma, Mirko Filippetti, Stefania Dalise, Valentina Azzollini, Carmelo Chisari, Stefania Spina, Nicoletta Cinone, Lorenza Scotti, Marco Invernizzi, Stefano Paolucci, Alessandro Picelli & Andrea Santamato. (2023) Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis: An observational longitudinal study. Frontiers in Neurology 14.
Crossref
Crossref
N. N. Spirin, D. V. Kiselev, N. S. Baranova & M. S. Karpova. (2023) Nociceptive and Mixed Pain Syndromes in Patients with Multiple Sclerosis. Neuroscience and Behavioral Physiology 53:3, pages 337-344.
Crossref
Crossref
İlknur Özkan, Cansu Polat Dunya & Serkan Demir. (2022) Life Experiences of Patients With Multiple Sclerosis About Their Spasticity: A Phenomenological Study. Clinical Nursing Research 32:1, pages 49-59.
Crossref
Crossref
Susanna Asseyer, Graham Cooper & Friedemann Paul. (2020) Pain in NMOSD and MOGAD: A Systematic Literature Review of Pathophysiology, Symptoms, and Current Treatment Strategies. Frontiers in Neurology 11.
Crossref
Crossref
Domenico Intiso, Valentina Simone, Michelangelo Bartolo, Andrea Santamato, Maurizio Ranieri, Maria Teresa Gatta & Filomena Di Rienzo. (2020) High Dosage of Botulinum Toxin Type A in Adult Subjects with Spasticity Following Acquired Central Nervous System Damage: Where Are We at?. Toxins 12:5, pages 315.
Crossref
Crossref
Lorenzo G. Mantovani, Paolo Cozzolino, Paolo A. Cortesi & Francesco Patti. (2020) Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis. Clinical Drug Investigation 40:4, pages 319-326.
Crossref
Crossref
Rachel Farrell & David Baker. (2019) An expert opinion: Optimisation of pharmacological management of multiple sclerosis related spasticity. Advances in Clinical Neuroscience & Rehabilitation.
Crossref
Crossref
Alessandro Enrico Grimaldi, Laura De Giglio, Shalom Haggiag, Assunta Bianco, Antonio Cortese, Sebastiano Giuseppe Crisafulli, Fabrizia Monteleone, Gerola Marfia, Luca Prosperini, Simonetta Galgani, Massimiliano Mirabella, Diego Centonze, Carlo Pozzilli & Letizia Castelli. (2019) The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray). PLOS ONE 14:7, pages e0219670.
Crossref
Crossref
Peter Flachenecker, Francesco Saccà & Carlos Vila. (2018) Variability of Multiple Sclerosis Spasticity Symptoms in Response to THC:CBD Oromucosal Spray: Tracking Cases through Clinical Scales and Video Recordings. Case Reports in Neurology 10:2, pages 169-176.
Crossref
Crossref
Giacomo Lus, Roberto Cantello, Maura Chiara Danni, Agusto Rini, Paola Sarchielli, Tiziana Tassinari & Elisabetta Signoriello. (2018) Palatability and oral cavity tolerability of THC:CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: a pilot study. Neurodegenerative Disease Management 8:2, pages 105-113.
Crossref
Crossref
E. V. Kostenko & A. N. Boiko. (2018) Treatment of a spastic increase of muscle tone in multiple sclerosis with botulinum toxin. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 118:7, pages 89.
Crossref
Crossref
Yasaman Safarpour & Bahman Jabbari. 2018. Botulinum Toxin Treatment in Clinical Medicine. Botulinum Toxin Treatment in Clinical Medicine
109
129
.
Sabrina Giacoppo, Placido Bramanti & Emanuela Mazzon. (2017) Sativex in the management of multiple sclerosis-related spasticity: An overview of the last decade of clinical evaluation. Multiple Sclerosis and Related Disorders 17, pages 22-31.
Crossref
Crossref
Yasaman Safarpour, Tahereh Mousavi & Bahman Jabbari. (2017) Botulinum Toxin Treatment in Multiple Sclerosis—a Review. Current Treatment Options in Neurology 19:10.
Crossref
Crossref
Pamela Latino, Letizia Castelli, Luca Prosperini, Maria Rita Marchetti, Carlo Pozzilli & Morena Giovannelli. (2017) Determinants of botulinum toxin discontinuation in multiple sclerosis: a retrospective study. Neurological Sciences 38:10, pages 1841-1848.
Crossref
Crossref
Alberto Gajofatto. (2016) Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis. Multiple Sclerosis and Related Disorders 8, pages 64-65.
Crossref
Crossref
Katarina Vesic, Slavica Djukic Dejanovic, Milica Borovcanin, Janko Samardzic & Gordana Toncev. (2016) Cannabis as a Possible Treatment for Spasticity in Multiple Sclerosis / Kanabis Kao Moguci Tretman U Lecenju Spasticnosti Kod Multiple Skleroze. Serbian Journal of Experimental and Clinical Research 17:1.
Crossref
Crossref
VL Stevenson, A Gras, JI Bárdos & J Broughton. (2015) The high cost of spasticity in multiple sclerosis to individuals and society. Multiple Sclerosis Journal 21:12, pages 1583-1592.
Crossref
Crossref
Jose Eustasio Meca‐Lallana, Rocío Hernández‐Clares & Ester Carreón‐Guarnizo. (2015) Spasticity in multiple sclerosis and role of glatiramer acetate treatment. Brain and Behavior 5:9.
Crossref
Crossref
Louise Jarrett. (2015) Being and becoming a spasticity nurse specialist: a reflexive narrative study. British Journal of Neuroscience Nursing 11:3, pages 129-136.
Crossref
Crossref
Rocco Salvatore Calabrò, Giangaetano D'Aleo, Edoardo Sessa, Antonino Leo, Maria Cristina De Cola & Placido Bramanti. (2014) Sexual Dysfunction Induced by Intrathecal Baclofen Administration: Is This the Price to Pay for Severe Spasticity Management?. The Journal of Sexual Medicine 11:7, pages 1807-1815.
Crossref
Crossref
Maria Galuppo, Sabrina Giacoppo, Placido Bramanti & Emanuela Mazzon. (2014) Use of Natural Compounds in the Management of Diabetic Peripheral Neuropathy. Molecules 19:3, pages 2877-2895.
Crossref
Crossref